| GB virus C: the good boy virus? N Bhattarai, JT Stapleton Trends in microbiology 20 (3), 124-130, 2012 | 192 | 2012 |
| Human pegivirus RNA is found in multiple blood mononuclear cells in vivo and serum-derived viral RNA-containing particles are infectious in vitro ET Chivero, N Bhattarai, RT Rydze, MA Winters, M Holodniy, JT Stapleton Journal of General Virology 95 (6), 1307-1319, 2014 | 87 | 2014 |
| CAR-T cell therapy: mechanism, management, and mitigation of inflammatory toxicities JW Fischer, N Bhattarai Frontiers in Immunology 12, 693016, 2021 | 80 | 2021 |
| Characterization of the effects of immunomodulatory drug fingolimod (FTY720) on human T cell receptor signaling pathways A Baer, W Colon-Moran, N Bhattarai Scientific reports 8 (1), 10910, 2018 | 54 | 2018 |
| GB virus C infection is associated with a reduced rate of reactivation of latent HIV and protection against activation-induced T-cell death RT Rydze, N Bhattarai, JT Stapleton Antiviral therapy 17 (7), 1271-1279, 2012 | 50 | 2012 |
| GB virus C particles inhibit T cell activation via envelope E2 protein-mediated inhibition of TCR signaling N Bhattarai, JH McLinden, J Xiang, AL Landay, ET Chivero, JT Stapleton The Journal of Immunology 190 (12), 6351-6359, 2013 | 43 | 2013 |
| GB virus C envelope protein E2 inhibits TCR-induced IL-2 production and alters IL-2–signaling pathways N Bhattarai, JH McLinden, J Xiang, TM Kaufman, JT Stapleton The Journal of Immunology 189 (5), 2211-2216, 2012 | 40 | 2012 |
| GB virus C viremia is associated with higher levels of double-negative T cells and lower T-cell activation in HIV-infected individuals receiving antiretroviral therapy N Bhattarai, RT Rydze, ET Chivero, JT Stapleton The Journal of infectious diseases 206 (9), 1469-1472, 2012 | 38 | 2012 |
| Characterization of a peptide domain within the GB virus C envelope glycoprotein (E2) that inhibits HIV replication J Xiang, JH McLinden, TM Kaufman, EL Mohr, N Bhattarai, Q Chang, ... Virology 430 (1), 53-62, 2012 | 35 | 2012 |
| Conserved motifs within hepatitis C virus envelope (E2) RNA and protein independently inhibit T cell activation N Bhattarai, JH McLinden, J Xiang, TM Kaufman, JT Stapleton PLoS pathogens 11 (9), e1005183, 2015 | 27 | 2015 |
| A novel T cell evasion mechanism in persistent RNA virus infection JT Stapleton, J Xiang, JH McLinden, N Bhattarai, ET Chivero, D Klinzman, ... Transactions of the American Clinical and Climatological Association 125, 14, 2014 | 27 | 2014 |
| Human Pegivirus (HPgV; formerly known as GBV-C) inhibits IL-12 dependent natural killer cell function ET Chivero, N Bhattarai, JH McLinden, J Xiang, JT Stapleton Virology 485, 116-127, 2015 | 26 | 2015 |
| Hepatitis C virus infection inhibits a Src-kinase regulatory phosphatase and reduces T cell activation in vivo N Bhattarai, JH McLinden, J Xiang, MM Mathahs, WN Schmidt, ... PLoS pathogens 13 (2), e1006232, 2017 | 17 | 2017 |
| Yellow Fever Virus, but Not Zika Virus or Dengue Virus, Inhibits T-Cell Receptor–Mediated T-Cell Function by an RNA-Based Mechanism JH McLinden, N Bhattarai, JT Stapleton, Q Chang, TM Kaufman, ... The Journal of infectious diseases 216 (9), 1164-1175, 2017 | 13 | 2017 |
| Src-family kinases negatively regulate NFAT signaling in resting human T cells A Baer, W Colon-Moran, J Xiang, JT Stapleton, N Bhattarai PLoS One 12 (10), e0187123, 2017 | 13 | 2017 |
| Chimpanzee GB virus C and GB virus A E2 envelope glycoproteins contain a peptide motif that inhibits human immunodeficiency virus type 1 replication in human CD4+ T-cells JH McLinden, JT Stapleton, D Klinzman, KK Murthy, Q Chang, ... Journal of General Virology 94 (4), 774-782, 2013 | 4 | 2013 |
| Characterization of “off-target” immune modulation induced by live attenuated yellow fever vaccine J Xiang, Q Chang, JH McLinden, N Bhattarai, JL Welch, TM Kaufman, ... The Journal of infectious diseases 229 (3), 786-794, 2024 | 3 | 2024 |
| Study design may explain discrepancies in GB virus C effects on interferon-γ and interleukin-2 production and CD38 expression in T lymphocytes N Bhattarai, JT Stapleton Memórias do Instituto Oswaldo Cruz 107, 568-569, 2012 | 3 | 2012 |
| A short hepatitis C virus NS5A peptide expression by AAV vector modulates human T cell activation and reduces vector immunogenicity W Colon-Moran, A Baer, G Lamture, JT Stapleton, JW Fischer, N Bhattarai Gene therapy 29 (10), 616-623, 2022 | 2 | 2022 |
| GB virus C (hepatitis G virus) E2 glycoprotein as an immunomodulatory agent JT Stapleton, N Bhattarai, J Xiang, JH McLinden US Patent 9,611,301, 2017 | 2 | 2017 |
